These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Screening and treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients in an urban multispecialty practice. Ledwich LJ; Clarke K J Clin Rheumatol; 2009 Mar; 15(2):61-4. PubMed ID: 19265346 [TBL] [Abstract][Full Text] [Related]
43. Gu Ling Pian, a traditional Chinese medicine, regulates function and OPG/RANKL synthesis of osteoblasts via the p38 MAPK pathway. Zhao Y; Li J; Liu Y; Yu KQ; Zhang J; Chen XG J Pharm Pharmacol; 2007 Aug; 59(8):1167-73. PubMed ID: 17725861 [TBL] [Abstract][Full Text] [Related]
44. Update on glucocorticoid-induced osteoporosis. Maricic M Rheum Dis Clin North Am; 2011 Aug; 37(3):415-31, vi. PubMed ID: 22023900 [TBL] [Abstract][Full Text] [Related]
46. An anti-inflammatory selective glucocorticoid receptor modulator preserves osteoblast differentiation. Rauch A; Gossye V; Bracke D; Gevaert E; Jacques P; Van Beneden K; Vandooren B; Rauner M; Hofbauer LC; Haegeman G; Elewaut D; Tuckermann JP; De Bosscher K FASEB J; 2011 Apr; 25(4):1323-32. PubMed ID: 21233489 [TBL] [Abstract][Full Text] [Related]
47. Skeletal morbidity in inflammatory bowel disease. van Hogezand RA; Hamdy NA Scand J Gastroenterol Suppl; 2006; (243):59-64. PubMed ID: 16782623 [TBL] [Abstract][Full Text] [Related]
48. Glucocorticoid-induced osteoporosis: from basic mechanisms to clinical aspects. Alesci S; De Martino MU; Ilias I; Gold PW; Chrousos GP Neuroimmunomodulation; 2005; 12(1):1-19. PubMed ID: 15756049 [TBL] [Abstract][Full Text] [Related]
49. [Glucocorticoid-induced osteoporosis]. Tóth M; Tulassay Z Orv Hetil; 2000 Jan; 141(5):219-23. PubMed ID: 10697979 [TBL] [Abstract][Full Text] [Related]
50. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin. Sambrook P; Birmingham J; Kelly P; Kempler S; Nguyen T; Pocock N; Eisman J N Engl J Med; 1993 Jun; 328(24):1747-52. PubMed ID: 7684512 [TBL] [Abstract][Full Text] [Related]
51. Glucocorticoid-induced osteoporosis: 2013 update. Mazzantini M; Di Munno O Reumatismo; 2014 Jul; 66(2):144-52. PubMed ID: 25069496 [TBL] [Abstract][Full Text] [Related]
52. Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-{kappa}B (RANK) ligand/RANK system. Liu XH; Kirschenbaum A; Yao S; Levine AC Endocrinology; 2005 Apr; 146(4):1991-8. PubMed ID: 15618359 [TBL] [Abstract][Full Text] [Related]